BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guillouzo A, Morel F, Fardel O, Meunier B. Use of human hepatocyte cultures for drug metabolism studies. Toxicology. 1993;82:209-219. [PMID: 8236275 DOI: 10.1016/0300-483x(93)90065-z] [Cited by in Crossref: 94] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 de Sousa G, Langouët S, Nicolas F, Lorenzon G, Placidi M, Rahmani R, Guillouzo A. Increase of cytochrome P-450 1A and glutathione transferase transcripts in cultured hepatocytes from dogs, monkeys, and humans after cryopreservation. Cell Biol Toxicol 1996;12:351-8. [PMID: 9034633 DOI: 10.1007/BF00438170] [Cited by in Crossref: 30] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Spielmann H, Bochkov NP, Costa L, Gribaldo L, Guillouzo A, Heindel JJ, Karol M, Parchment R, Pfaller W, Peraita PP, Zacharewski T. 13th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies for organ toxicity. Environ Health Perspect 1998;106 Suppl 2:427-39. [PMID: 9599689 DOI: 10.1289/ehp.98106427] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
3 Miyagi SJ, Brown IW, Chock JM, Collier AC. Developmental changes in hepatic antioxidant capacity are age-and sex-dependent. J Pharmacol Sci. 2009;111:440-445. [PMID: 20019448 DOI: 10.1254/jphs.09223sc] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
4 Ueyama T, Tsuji S, Sugiyama T, Tada M. Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7. Sci Rep 2017;7:2874. [PMID: 28588200 DOI: 10.1038/s41598-017-03146-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Norona LM, Nguyen DG, Gerber DA, Presnell SC, LeCluyse EL. Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Toxicol Sci 2016;154:354-67. [PMID: 27605418 DOI: 10.1093/toxsci/kfw169] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 17.0] [Reference Citation Analysis]
6 Yang LQ, Yu WF, Cao YF, Gong B, Chang Q, Yang GS. Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol 2003; 9(9): 1959-1962 [PMID: 12970884 DOI: 10.3748/wjg.v9.i9.1959] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
7 Underhill GH, Khetani SR. Bioengineered Liver Models for Drug Testing and Cell Differentiation Studies. Cell Mol Gastroenterol Hepatol 2018;5:426-439.e1. [PMID: 29675458 DOI: 10.1016/j.jcmgh.2017.11.012] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 18.5] [Reference Citation Analysis]
8 Ooeda K, Kubiura-Ichimaru M, Tsuji S, Okuyama S, Yamashita M, Mine A, Kawamura F, Ueyama T, Tada M. A two-dimensional multiwell cell culture method for the production of CYP3A4-expressing hepatocyte-like cells from HepaRG cells. Pharmacol Res Perspect 2020;8:e00652. [PMID: 32955797 DOI: 10.1002/prp2.652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]